Calendar
Prev MonthPrev Month Next MonthNext Month
Webinar: What the Heck Now?! Late Onset Cancer Treatment Toxicities
Friday, June 26, 2020, 12:00 PM - 1:00 PM MDT
Category: Quarterly Webinars

CPS Quarterly Webinar

What the Heck Now?! Late Onset Cancer Treatment Toxicities

Date: Friday, June 26, 2020
Time: 12:00PM - 1:00PM
Speaker: Jared Freml, PharmD, BCOP, Clinical Pharmacy Specialist in Oncology at Kaiser Permanente Colorado
Registration: Members: FREE | Non-Members: $10.00
Continuing Education Credits: 1.0 CPE 


Registration Form


Description:

Cancer therapy has evolved greatly over the past 20 years. During this time 150 new agents have been approved by the FDA, and late onset toxicities that occur as a result of new cancer therapies differ from traditional cytotoxic chemotherapy. Because 5 year cancer survival rates have reached 70%, pharmacists in many areas of practice will increasingly be exposed to late onset toxicity management. This program will provide an introduction to the late onset toxicities seen with novel therapies compared to traditional treatments.

 

Objectives:

  • Recall common late onset side effects associated with cytotoxic chemotherapy and oral cancer therapies
  • Explain the mechanisms of action of immune checkpoint inhibitors
  • Describe late onset toxicities associated with immune checkpoint inhibitors
  • Summarize management recommendations for immune checkpoint inhibitor toxicities
Continuing Education Information

The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).  This activity has been accredited for 1.0 contact hours of knowledge-based CPE for pharmacists and pharmacy technicians.  To receive CPE, participants must create a profile on ipharmCE.UCDenver.edu with their NABP eProfile ID number and birthdate, and complete the activity evaluation by July 31, 2020.  CPE credit will be uploaded to CPE Monitor upon completion of the activity evaluation.

UAN #0008-9999-20-046-L05-P/T    
Release: 06/26/2020
Expire: 06/26/2023